MedTrace Logo

Cannabis Consumption and Driving Impairment Assessment on a Closed Course

NCT06059677 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2023-09-29

No results posted yet for this study

Summary

In a true experiment, roughly 300 volunteer participants will smoke active cannabis, a corresponding placebo, or no substance at all (control). Next, participants will complete a drive test and then be observed by actual California Highway Patrol (CHP) officers who will attempt to classify participants as impaired or unimpaired. CHP Officers will evaluate participants in the context of driving (i.e., while following participants in an actual patrol car), as part of a roadside behavioral assessment (i.e., the Advanced Roadside Impaired Driving Enforcement, or ARIDE, battery, which includes Standardized Field Sobriety Tests, or SFSTs), and as part of a Drug Recognition Expert (DRE) evaluation conducted indoors.

Conditions

  • Cannabis Smoking
  • Driving Impaired

Interventions

DRUG

Active smoked cannabis

Assessment of active cannabis smoking and driving impairment

DRUG

Placebo smoked cannabis

Assessment of placebo cannabis smoking and driving impairment

Sponsors & Collaborators

  • Bayliss J. Camp, PhD

    lead OTHER_GOV

Principal Investigators

  • Bayliss J Camp, PhD · California Department of Motor Vehicles

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-03
Primary Completion
2024-12-31
Completion
2024-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06059677 on ClinicalTrials.gov